Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Aridis Pharmaceuticals In...

    OTC: ARDS · Real-Time Price · USD
    0.00
    -0.00 (-100.00%)
    At close: Apr 01, 2025, 9:51 AM

    Aridis Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a
    Cost of Revenue
    		 n/a n/a
    Gross Profit
    		 n/a n/a
    Operating Income
    		 -29.99M -43.71M
    Interest Income
    		 n/a n/a
    Pretax Income
    		 -30.37M -43.19M
    Net Income
    		 -30.75M -42.28M
    Selling & General & Admin
    		 7.16M 7.31M
    Research & Development
    		 25.92M 37.94M
    Other Expenses
    		 -3.09M -1.53M
    Operating Expenses
    		 29.99M 43.71M
    Interest Expense
    		 378K -245K
    Selling & Marketing Expenses
    		 n/a n/a
    Cost & Expenses
    		 29.99M 43.71M
    Income Tax Expense
    		 378K -912K
    Shares Outstanding (Basic)
    		 18.78M 12.29M
    Shares Outstanding (Diluted)
    		 18.78M 12.29M
    EPS (Basic)
    		 -1.64 -3.44
    EPS (Diluted)
    		 -1.64 -3.44
    EBITDA
    		 -29.51M -44.43M
    EBIT
    		 n/a -43.44M
    Depreciation & Amortization
    		 487K -722K

    Add to Watchlist